Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
GlaxoSmithKline
>
New Forbes article questions impact of PF
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 5294631"]Thanks PR boy. How about some accountability for their mistakes? Management acts like morons and we pay for it by losing our jobs. GSK will not be OK until the people at the top are wiped out. You can't make disasterous decisions and have any credibility with Walll Stor within the organization . It's time to take out the trash at the top.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 5294631"]Thanks PR boy. How about some accountability for their mistakes? Management acts like morons and we pay for it by losing our jobs. GSK will not be OK until the people at the top are wiped out. You can't make disasterous decisions and have any credibility with Walll Stor within the organization . It's time to take out the trash at the top.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
GlaxoSmithKline
>
New Forbes article questions impact of PF
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
GlaxoSmithKline
>
New Forbes article questions impact of PF
>